EichorEICHOR
Study identifier: NCT05050955 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

AlloSure Lung Assessment and Metagenomics Outcomes Study

Condition: Lung Transplant Infection · Lung Transplant; Complications · Lung Transplant Failure and Rejection  ·  Sponsor: CareDx

PhaseN/A
Planned participants550
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

ALAMO is a prospective, multi-center, perspective, registry of patients receiving LungCare™ (AlloSure®-Lung, AlloMap Lung, and HistoMap) for surveillance post-transplant. This study aims to evaluate the diagnostic performance characteristics of AlloSure Lung (dd-cfDNA) to detect a spectrum of rejection (ACR, AMR) and allograft infection (Bacterial, Viral, Fungal, Mycobacterial, Parasitic).

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (22)

University of Alabama (UAB)Birmingham, Alabama, United States
St. Joseph's Hospital & Medical CenterPhoenix, Arizona, United States
Cedars Sinai Medical CenterLos Angeles, California, United States
University of California (UCSF) School of MedicineSan Francisco, California, United States
University of CO Anschutz Medical CampusAurora, Colorado, United States
AdventHealth OrlandoOrlando, Florida, United States
Loyola University Medical SchoolMaywood, Illinois, United States
University of Louisville HealthLouisville, Kentucky, United States
University of MaylandBaltimore, Maryland, United States
Brigham and Womens HospitalBoston, Massachusetts, United States
Washington University-Barnes Jewish HospitalSt Louis, Missouri, United States
NYU Langone HealthNew York, New York, United States

+ 10 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →